Company page

Alkermes Plc

Alkermes Plc is a public company traded on the American stock market under the ticker ALKS. With a market capitalization of approximately $7.5 billion, Alkermes focuses on developing innovative treatments for central nervous system disorders. The company is committed to improving patient outcomes through its research and product offerings.